Synthesis of the steroidal glycoside (25R)-3 beta,16 beta-diacetoxy-12,22-dioxo-5 alpha-cholestan-26-yl beta-D-glucopyranoside and its anti-cancer properties on cervicouterine HeLa, CaSki, and ViBo cells
The synthesis of the new glycoside (25R)-3 beta,16 beta-diacetoxy-12,22-dioxo-5 alpha-cholestan-26-yl beta-D-glucopyranoside starting from hecogenin is described. This compound showed anti-cancer activity against cervicouterine cancer cells HeLa. CaSki and ViBo in the micromolar range. Its effect on...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2010 |
| País: | México |
| Institución: | Universidad Nacional Autónoma de México |
| Repositorio: | Sistema de Información de la Facultad de Ciencias, UNAM |
| OAI Identifier: | oai:repositorio.fciencias.unam.mx:11154/34 |
| Acceso en línea: | http://hdlhandlenet/123456789/263 |
| Access Level: | acceso abierto |
| Palabra clave: | Chemistry, Medicinal Steroidal glycoside HeLa CaSki ViBo Antiproliferative activity Apoptosis |
| Sumario: | The synthesis of the new glycoside (25R)-3 beta,16 beta-diacetoxy-12,22-dioxo-5 alpha-cholestan-26-yl beta-D-glucopyranoside starting from hecogenin is described. This compound showed anti-cancer activity against cervicouterine cancer cells HeLa. CaSki and ViBo in the micromolar range. Its effect on cell proliferation, cell cycle and cell death is also described. The cytotoxic effect of the title compound on HeLa, CaSki and ViBo cells and human lymphocytes was evaluated through the LDH released in the culture supernatant, indicating that the main cell death process is not necrosis |
|---|